Archive - July 2021
J&J, distributors reach $26bn settlement to address the opioid crisis in the US
Novartis sees demand returning to pre-COVID-19 levels in Q2 results
Merck, Eisai’s Keytruda/Lenvima regimen scores full approval in endometrial cancer
Albireo’s Bylvay approved in EU and US for rare paediatric liver disease
Nanopharm and Leyden Labs link up in nasal spray partnership
MSD, Bayer’s heart failure med Verquvo gains EU approval
NICE recommends Incyte’s Pemazyre for rare bile duct cancer
Vaccine Passports: What Businesses Need To Know – And Why They Should Have More Say